Serum metabolome associated with severity of acute traumatic brain injuryShow others and affiliations
2022 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 13, no 1, article id 2545Article in journal (Refereed) Published
Abstract [en]
Complex metabolic disruption is a crucial aspect of the pathophysiology of traumatic brain injury (TBI). Associations between this and systemic metabolism and their potential prognostic value are poorly understood. Here, we aimed to describe the serum metabolome (including lipidome) associated with acute TBI within 24 h post-injury, and its relationship to severity of injury and patient outcome. We performed a comprehensive metabolomics study in a cohort of 716 patients with TBI and non-TBI reference patients (orthopedic, internal medicine, and other neurological patients) from the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) cohort. We identified panels of metabolites specifically associated with TBI severity and patient outcomes. Choline phospholipids (lysophosphatidylcholines, ether phosphatidylcholines and sphingomyelins) were inversely associated with TBI severity and were among the strongest predictors of TBI patient outcomes, which was further confirmed in a separate validation dataset of 558 patients. The observed metabolic patterns may reflect different pathophysiological mechanisms, including protective changes of systemic lipid metabolism aiming to maintain lipid homeostasis in the brain.
Place, publisher, year, edition, pages
Nature Publishing Group, 2022. Vol. 13, no 1, article id 2545
National Category
Neurosciences
Identifiers
URN: urn:nbn:se:oru:diva-98979DOI: 10.1038/s41467-022-30227-5ISI: 000793456800026PubMedID: 35538079Scopus ID: 2-s2.0-85130005214OAI: oai:DiVA.org:oru-98979DiVA, id: diva2:1657730
Funder
European Commission, 602150Swedish Research Council, 2018-02629Academy of Finland, 17379
Note
Funding agencies:
OneMind (US)
Hannelore Kohl Foundation (DE)
NeuroTrauma Sciences (US)
Integra Neurosciences
Government's Special Financial Transfer tied to academic research in Health Sciences, Finland 11129
Maire Taponen Foundation
2022-05-122022-05-122024-12-19Bibliographically approved